HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$3.23
Day range
$3.14 - $3.45
Year range
$2.47 - $20.60
Market cap
13.57M USD
Avg Volume
40.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.69M | -55.35% |
Net income | -5.30M | -124.81% |
Net profit margin | — | — |
Earnings per share | -0.53 | -76.67% |
EBITDA | -5.64M | 55.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.20M | -43.34% |
Total assets | 14.98M | -41.20% |
Total liabilities | 5.06M | -48.36% |
Total equity | 9.92M | — |
Shares outstanding | 4.24M | — |
Price to book | 1.71 | — |
Return on assets | -96.11% | — |
Return on capital | -141.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.30M | -124.81% |
Cash from operations | -4.34M | 60.19% |
Cash from investing | -5.88K | 90.41% |
Cash from financing | 4.99M | — |
Net change in cash | 641.74K | 105.85% |
Free cash flow | -2.89M | 82.74% |
About
Founded
1996
Headquarters
Website
Employees
11
